Arcus Biosciences, Inc.
INHIBITORS OF ARG1 AND/OR ARG2
Last updated:
Abstract:
Compounds that are inhibitors of at least one of ARG1 and ARG2, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by ARG1 and ARG2 are also described herein.
Status:
Application
Type:
Utility
Filling date:
15 Nov 2019
Issue date:
20 Jan 2022